Reciprocal synaptic relationships between orexin- and melanin-concentrating hormone-containing neurons in the rat lateral hypothalamus: A novel circuit implicated in feeding regulation

International Journal of Obesity

Volumn 26, Issue 12, 2002, Pages 1523-1532

  Guan, J L ^a   Uehara, K ^a   Lu, S ^a   Wang, Q P ^a   Funahashi, H ^a   Sakurai, T ^b   Yanagizawa, M ^c   Shioda, S ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Granular vesicle; Immunocytochemistry; Silver gold intensification; Synapse; Ultrastructure

Indexed keywords

MELANIN CONCENTRATING HORMONE; OREXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRUCTURE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; FEEDING; FOOD INTAKE; IMMUNOHISTOCHEMISTRY; LATERAL HYPOTHALAMUS; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE;

ANIMALS; CARRIER PROTEINS; EATING; HYPOTHALAMIC AREA, LATERAL; HYPOTHALAMIC HORMONES; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MELANINS; MICROSCOPY, ELECTRON; NEURONS; NEUROPEPTIDES; PITUITARY HORMONES; RATS; RATS, WISTAR; SYNAPSES;

ANIMALIA;

EID: 0036949711     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802155     Document Type: Article

References (50)

1. Anand BK, Brobeck JR. Hypothalamic control of food intake in rats and cats. Yale J Biol Med 1951; 24: 123-146.
2. Bernardis LL, Bellinger LL. The lateral hypothalamic area revisited: ingestive behavior. Neurosci Biobehav Rev 1996; 20: 189-287.
3. Luiten PG, ter Horst GJ, Steffens AB. The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism. Prog Neurobiol 1987; 28: 1-54.
4. Steinbaum EA, Miller NE. Obesity from eating elicited by daily stimulation of hypothalamus. Am J Physiol 1965; 208: 1-5.
5. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek J, Kanarek R, Maratos-Flier E. A role for melanin-concentrating hormone in the central regulation of feeding behavior. Nature 1996, 380: 243-247.
6. Jezová D, Bartanusz V, Westergren I, Johansson BB, Rivier J, Vale W, Rivier C. Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier. Endocrinology 1992; 130: 1024-1029.
7. Rossi M, Choi SJ, O'Shea D, Miyoshi T, Ghatei MA, Bloom SR. Melanin-concentrating hormone acutely stimulats feeding, but chronic administration has no effect on body weight. Endocrinology 1997; 138: 351-355.
8. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JRS, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu W-S, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-585.
9. Presse F, Sorokovsky I, Max J-P, Nicolaidis S, Nahon J-L. Melanin-concentrating hormone is a potent anorectic peptide regulated by food deprivation and glucopenia in the rat. Neuroscience 1996; 71: 735-745.
10. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 1998; 396: 670-674.
11. Bittencourt JC, Presse F, Arias C, Peto C, Vaughan J, Nahon J-L, Vale W, Sawchenko PE. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol 1992; 319: 218-245.
12. Chen CT, Dun SL, Kwok EH, Dun NJ, Chang J-K. Orexin A-like immunoreactivity in the rat brain. Neurasci Lett 1999; 260: 161-164.
13. Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 1999; 827: 243-260.
14. Naito N, Kawazoe I, Nakai Y, Kawauchi H. Melanin-concentrating hormone-like immunoreactive material in the rat hypothalamus; characterization and subcellular localization. Cell Tiss Res 1988; 253: 291-295.
15. Zhang JH, Sampogna S, Morales FR, Chase MH. Orexin (hypocretin)-like immunoreactivity in the cat hypothalamus: a light and electron microscopic study. Sleep 2001; 24: 67-76.
16. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001; 435: 6-25.
17. Saito Y, Cheng M, Leslie FM, Civelli O. Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain. J Comp Neurol 2001; 435: 26-40.
18. Guan J-L, Saotome T, Wang Q-P, Funahashi H, Hori T, Tanaka S, Shioda S. Orexinergic innervation of POMC-containing neurons in the rat arcuate nucleus. Neuro Report 2001; 12: 547-551.
19. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580.
20. Wang Q-P, Nakai Y. Double preembedding immunostaining for the study by electron microscopy of synaptic relationships between immunocytochemically identified neurons. Neurosci Protoc 1996; 50: 05-01-13.
21. Horvath TL, Diano S, van den Pol AN. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci 1999; 19: 1072-1087.
22. Horvath TL, Peyron C, Diano S, Ivanov A, Aston Jones G, Kilduff TS, van den Pol AN. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol 1999; 415: 145-159.
23. de Lecea L, Kilduff T, Peyron C, Gao X-B, Foye PE, Danuelson PE, Fukuhara C, Battenberg ELF, Gautvik VT, Bartlett II FS, Frankel WN, van den Pol AN, Bloom FG, Gautvik KM, Sutcliffe JG. The hypocretins: hypothalamus-specific peptides with neuro-excitatory activity. Proc Nalt Acad Sci USA 1998; 95: 322- 327.
24. Broberger C, De Lecea L, Sutcliffe JG, Hökfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 1998; 402: 460-474.
25. Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J, Tatro JB, Hofffnan GE, Ollmann MM, Barsh GS, Sakurai T, Yanagisawa M, Elmquist JK. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 1998; 402: 442-459.
26. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998; 18: 9996-10015.
27. Haynes AC, Jackson B, Chapman H, Tadayyon M, Johns A, Porter RA, Arch JR. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul Pept 2000; 96: 45-51.
28. Ida T, Nakahara K, Kuroiwam T, Fukui K, Nakazato M, Murakami T, Murakami N. Both corticotropin releasing factor and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats. Neurosci Lett 2000; 293: 119-122.
29. Li MD, Parker SL, Kane JK. Regulation of feeding-associated peptides and receptors by nicotine. Mol Neurobiol 2000; 22: 143-165.
30. Niimi M, Sato M, Taminato T. Neuropeptide Y in central control of feeding and interactions with orexin and leptin. Endocrine 2001; 14: 269-273.
31. Xi M-C, Morales FR, Chase MH. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res 2001; 901: 259-264.
32. Methippara MM, Alam MN, Szymusiak R, McGinty D. Effects of lateral preoptic area application of orexin-A on sleep-wakefulness. Neuro Report 2000; 11: 3423-3426.
33. Bourgin P, Huitron-Resendiz S, Spier AD, Fabre V, Morte B, Criado JR, Sutcliffe JG, Henriksen SJ, de Lecea L. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 2000; 20: 7760-7765.
34. Jaszberenyi M, Bujdoso E, Pataki I, Telegdy G. Effects of orexins on the hypothalamic-pituitary-adrenal system. J Neuroendocrinol 2000; 12: 1174-1178.
35. Kuru M, Ueta Y, Serino R, Nakazato M, Yamamoto Y, Shibuya I, Yamashita H. Centrally administrered orexin/hypocretin activates HPA axis in rats. Neuro Report 2000; 11: 1977-1980.
36. Russell SH, Kim MS, Smell CJ, Abbott CR, Morgan DG, Taheri S, Murphy KG, Todd JF, Ghatei MA, Bloom SR. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin. J Neuroendocrinol 2000; 12: 1213-1218.
37. Russell SH, Smell CJ, Dakin CL, Abbott CR, Morgan DG, Ghatei MA, Bloom SR. The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. J Neuroendocrinol 2001; 13: 561-566.
38. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27: 469-474.
39. van den Pol AN. Narcolepsy: a neurodegenerative disease of the hypocretin system? Neuron 2000; 27: 415-418.
40. Yoshimichi G, Yoshimatsu H, Masaki T, Sakata T. Orexin-A regulates body temperature in coordination with arousal status. Exp Biol Med (Maywood) 2001; 226: 468-476.
41. Kiyashchenko LI, Mileykovskiy BY, Lai YY, Siegel JM. Increased and decreased muscle tone with orexin (hypocretin) micro-injections in the locus coeruleus and pontine inhibitory area. J Neurophysiol 2001; 85: 2008-2016.
42. Bingham S, Davey PT, Babbs AJ, Irving EA, Sammons MJ, Wyles M, Jeffrey P, Cutler L, Riba I, Johns A, Porter RA, Upton N, Hunter AJ, Parsons AA. Orexin-A, an hypothalamic peptide with analgesic properties. Pain 2001; 92: 81-90.
43. Gonzalez MI, Kalia V, Hole DR, Wilson CA. α-Melanocyte-stimulating hormone (α-MSH) and melanin-concentrating hormone (MCH) modify monoaminergic levels in the preoptic area of the rat. Peptides 1997; 18: 387-392.
44. Tsukamura H, Thompson RC, Tsukahara S, Ohkura S, Maekawa F, Moriyama R, Niwa Y, Foster DJ, Maeda K. Intracerebro-ventricular administration of melanin-concentrating hormone suppresses pulsatile luteinizing hormone release in the female rat. J Neuroendocrinol 2000; 12: 529-534.
45. Chiocchio SR, Gallardo MG, Louzan P, Gutnisky V, Tramezzani JH. Melanin-concentrating hormone stimulates the release of luteinizing hormone-releasing hormone and gonadotropins in the female rat acting at both median eminence and pituitary levels. Biol Reprod 2001; 64: 1466-1472.
46. Gilchriest BJ, Tipping DJ, Hake L, Levy A, Baker BI. Differences in arginine vasotocin gene transcripts and cortisol secretion in trout with high or low endogenous melanin-concentrating hormone secretion. J Neuroendocrinol 2001; 13: 407-411.
47. Gilham ID, Baker BI. Evidence for the participation of a melanin-concentrating hormone in physiological colour change in the eel. J Endocrinol 1984; 102: 237-243.
48. Baker BI, Eberle AN, Baumann JB, Siegrist W, Girard J. Effect of melanin concentrating hormone on pigment and adrenal cells in vitro. Peptides 1985; 6: 1125-1130.
49. Oshima N, Kasukawa H, Fujii R, Wilkes BC, Hruby VJ, Castrucci AM, Hadley ME. Melanin concentrating hormone (MCH) effects on teleost (Chrysiptera cyanea) melanophores. J Exp Zool 1985; 235: 175-180.
50. van den Pol AN, Gao XB, Obrietan K, Kilduff TS, Belousov AB. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 1998; 18: 7962-7971.